This compound is a pharmaceutical intermediate used as a reference standard for identifying and quantifying impurities in Acalabrutinib. It features a complex polycyclic structure with multiple aromatic rings and amide functional groups, making it suitable for analytical quality control in pharmaceutical manufacturing.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 2490433-97-9
Acalabrutinib Impurity 21
pharmaceutical impurity reference standard
(2R)-2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)-1-Pyrrolidinecarboxylic acid phenylmethyl ester
Acalabrutinib impurity reference standard
Acalabrutinib Impurity 10
Acalabrutinib impurity reference standard
ALANINE METHYL ESTER HYDROCHLORIDE
peptide synthesis building block
Ethyl (3R)-3-hydroxybutanoate
Pharmaceutical intermediate for drug synthesis
Dexamethasone 9,11-Epoxide
Pharmaceutical intermediate for dexamethasone synthesis
2-Chloro-1,3-bis(dimethylamino)trimethinium hexafluorophosphate
pharmaceutical intermediate
4-[5-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]-10-methyl-12-oxo-4,6,9,13-tetrazatricyclo[7.4.0.02,6]trideca-1(13),2,4,7,10-pentaen-3-yl]-N-pyridin-2-ylbenzamide
DBIHVGGBNOQUGX-QFIPXVFZSA-N
CC#CC(=O)N1CCC[C@H]1C2=NC(=C3N2C=CN4C3=NC(=O)C=C4C)C5=CC=C(C=C5)C(=O)NC6=CC=CC=N6